BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Sarah Cannon Research Institute UK And BioMarin Pharmaceutical Inc. (BMRN) Collaborate On EMBRACA Clinical Study In Hereditary Breast Cancer With BRCA Mutation 7/23/2014 12:53:41 PM
BioMarin Pharmaceutical Inc. (BMRN) To Host Second Quarter 2014 Financial Results Conference Call And Webcast On Wednesday, July 30 At 4:30pm ET 7/9/2014 10:38:14 AM
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIMâ„¢ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014 9:00:24 AM
BioMarin Pharmaceutical Inc. (BMRN) To Present At The Wells Fargo Healthcare Conference On June 17th 6/10/2014 9:53:27 AM
BioMarin Pharmaceutical Inc. (BMRN) Doses First Patient In Phase 3 INSPIRE Trial With BMN 701 For The Treatment Of Pompe Disease 5/27/2014 9:05:37 AM
BioMarin Pharmaceutical Inc. (BMRN) To Present At The Bank of America (BAC) Merrill Lynch 2014 Healthcare Conference On May 14th And The UBS Global Healthcare Conference On May 20th 5/6/2014 9:49:10 AM
Rare Disease Drugmaker BioMarin Pharmaceutical Inc. (BMRN) To Create 50 New Jobs In Ireland 5/2/2014 6:49:35 AM
BioMarin Pharmaceutical Inc. (BMRN) Announces First Quarter 2014 Financial Results And VIMIZIM™ Launch Progress 5/1/2014 4:17:09 PM
BioMarin Pharmaceutical Inc. (BMRN) Announces European Commission Approval For VIMIZIM® (Elosulfase Alfa) For The Treatment Of Morquio A Syndrome In Patients Of All Ages 4/28/2014 11:05:47 AM
BioMarin Pharmaceutical Inc. (BMRN) To Host First Quarter 2014 Financial Results Conference Call And Webcast On Thursday, May 1 At 5:00 P.M. ET 4/16/2014 9:21:52 AM
12345678910...